Genomic Tumor

An innovative combination of drug sensitivity testing and genomics helped identify therapeutic options for children with relapsed or refractory solid or hematologic malignancies, according to results published in Nature Medicine.

Knowledge, expectations and attitudes of patients with cancer about genomic tumor testing appeared to be associated with their respective education and income levels, according to a study published in JCO Precision Oncology.

Genomic testing continues to provide oncologists with a wealth of meaningful, treatment-guiding information for a growing number of cancers.